arginyl-glycyl-aspartic acid has been researched along with Cataract, Membranous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emiroğlu, L; Güler, C; Ilker, SS; Kaynak, S; Kurt, E; Ozer, E; Oztürk, F | 1 |
| Baatz, H; Hartmann, C; Kojetinsky, C; Pleyer, U; Rieck, P | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Cataract, Membranous
| Article | Year |
|---|---|
Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents.
Topics: Animals; Cataract; Dexamethasone; Diclofenac; Drug Therapy, Combination; Edetic Acid; Epithelial Cells; Lens Capsule, Crystalline; Mitomycin; Oligopeptides; Phacoemulsification; Rabbits | 2001 |
[In vitro bovine and human lens epithelial cell culture studies on inhibition of posterior capsule opacification using a cyclic RGD peptide].
Topics: Adhesiveness; Animals; Antineoplastic Agents; Cataract; Cattle; Cells, Cultured; Epithelial Cells; Humans; Lens, Crystalline; Oligopeptides; Time Factors | 2001 |